Product Images Estradiol

This text provides information about a product called Estradiol Gel 0.1%. It is manufactured in Spain by Laborstorios edn Farm, SA and distributed by Xromed,UC. The NDC number for the product is 70700-143-35. The product comes in 30 packets, and each packet contains 0.25 g gel that provides 0.25 mg estradiol. The text also includes safety warnings to contact a doctor about any side effects and mentions the Xromed website.*

This is a description of a medication called Estradiol Gel 0.1%. Each packet contains 0.5mg of estradiol, and there are 30 packets in a box. It is manufactured by Laboratory of Farm S. P, Navateer, and sold by Siromed. The medication is intended for the treatment of certain medical conditions. It was made in Spain and must be stored at temperatures between 15-30 C. Before use, it is important to consult with a physician about side effects and administration.*

This is a description of a medication called Estradiol Gel 0.1%. The package contains 30 packets of the gel with 0.75 mg Etadl per packet. It also lists the manufacturer, Laboratorios Ledn Farm, SA located in Spain, and the distributor, Xromed, LLC located in the US. The NDC code for the product is 70700-194-35 and there is a warning to keep it out of reach of children. Administration and storage instructions are provided.*

This is a product description for a box of 30 packets of Estradiol Gel 0.1%. Each packet contains 1.25 g of gel which provides 1.25 mg estradiol/packet. The dosage and administration instructions are not available due to issues, but it warns to keep the package out of children's reach and avoid opening it with smoking materials around. It also provides the manufacturer and distributor information, as well as contact information for the doctor if needed. The product of Spain is distributed by Xromed, LLC.*

This appears to be a product description for a medication called XIROMED that comes in packets containing a gel formulation. Each packet provides 1 mg of estradiol. The text includes some identifying codes and information about distribution.*

Table 2 presents the Mean (%CV) Pharmacokinetic Parameters for Estradiol on Day 14 following daily doses of different strengths (0.25g, 0.5g, and 1.0g) of Estradiol Gel 0.1%, where various parameters such as AUC, Cone, Cavg, ta, and E2E1 ratio were measured. Median values with minimum and maximum ranges were also provided.*

This is a summary table of the changes in the median daily frequency and severity of hot flushes from baseline with Estradiol Gel 0.1% treatment in the ITT population. The table presents the data for different dosages of the gel and a placebo. The frequency and severity of hot flushes were significantly reduced with Estradiol Gel 0.1% treatment compared to the placebo. The p-values from the van Lteren's test were stratified by pooled center, and the comparison in median change was significant if p<0.05.*